• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Malposition of Device (2616)
Patient Problem Aortic Regurgitation (1716)
Event Date 11/08/2019
Event Type  Injury  
Manufacturer Narrative
The manufacturer received the device back on dec.02, 2019.The device was received in good conditions and no abnormalities were observed.Based on the information provided the event was a malpositioning leading to paravalvular leak.The site performed an intra-operative explant and this caused a delay of 26 minutes.The event information indicates that the root cause was the malpositioning of the device and thus there is no device related malfunction or insufficiency.The manufacturer will not perform any further investigations and the root cause is determined to be user error - malpositioning.
 
Event Description
On (b)(6) 2019 a patient received a perceval pvs23 sutureless aortic heart valve as part of an avr.The patient was indwelled through a midline incision.Transesophageal echocardiography(tee) was performed after de-clamping, and it showed that the non-coronary cusp(ncc) of the device was placed slightly higher and there was perivalvular leakage.So the device was explanted and another perceval(serial# (b)(4)) was indwelled.The first x-clamp time was 26 minutes.The second x-clamp time was 35 minutes.Total cpb time was 146 minutes.The patient's condition was stable during this operation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
Manufacturer (Section G)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc V5J 5 M1
CA   V5J 5M1
Manufacturer Contact
francesca crovato
5005 n fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
MDR Report Key9433925
MDR Text Key171971304
Report Number3004478276-2019-00328
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)220127
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/27/2022
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/02/2019
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received11/08/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/27/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
Patient Weight65
-
-